Fig. 1 · Structure
Documents & Downloads
ACT-209905
S1P1 Receptor Agonist
ACT-209905 is an agonist of the S1P1 receptor, demonstrating potent inhibition of glioblastoma (GBM) cell growth and migration. In addition to its antitumor properties, ACT-209905 exhibits immunomodulating activity, making it a valuable tool for investigating autoimmune diseases. This compound is suitable for research applications aimed at elucidating the roles of S1P1 signaling in cancer and immune regulation.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Agonist |
| CAS Number | 1062670-13-6 |
| Applications | S1P1 Receptor Agonist |
| Formula | C26H35N5O5 |
| Molecular Weight | 497.59 |
| SMILES | O=C(NC[C@H](O)COC1=C(C)C=C(C2=NOC(C3=CC(N(CC)CC)=NC(C)=C3)=N2)C=C1CC)CO |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.